| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |